On this page
Cardiovascular items on the FNP boards test prevention as much as treatment. Many turn on a USPSTF grade: who should get a statin, who should not start aspirin, who gets a one-time aneurysm scan. The rest test drug safety rules straight from the label. The 13 questions below cover both.
They are written for candidates using FNP-C exam prep, which is built on the NPCB (formerly AANPCB) FNP blueprint. For how the blueprint weights domains and age groups, see the AANP FNP exam blueprint guide.
This set is exam practice written from the USPSTF, CDC, AAP and FDA label sources listed under References. The questions are original PrepSolution items, not NPCB or ANCC exam questions. It is not clinical guidance for any patient, and it has not been reviewed by a credentialed nurse practitioner.
Lipids and aspirin
Question 1: Who gets a statin
A 52-year-old with hypertension, no known cardiovascular disease, has an estimated 10-year CVD risk of 12%. Which action matches the USPSTF statin recommendation?
- A. Prescribe a statin for primary prevention
- B. No statin until LDL exceeds 190 mg/dL
- C. Selectively offer a statin after shared decision-making only
- D. Recheck risk in 5 years before deciding
Best answer: A. USPSTF recommends that clinicians prescribe a statin for primary prevention for adults aged 40 to 75 with one or more CVD risk factors (dyslipidemia, diabetes, hypertension or smoking) and a 10-year risk of 10% or greater. Grade B.
- B is not the best answer. The recommendation is based on risk factors and 10-year risk, not an LDL threshold.
- C is not the best answer. Selective offering is the USPSTF approach for 7.5% to under 10% risk. At 12% the recommendation is to prescribe.
- D is not the best answer. The recommendation applies now; it does not call for deferring the decision.
Question 2: The middle-risk group
A 61-year-old who smokes has a 10-year CVD risk of 8.5%. What does USPSTF recommend about a statin?
- A. Prescribe for everyone in this group
- B. Selectively offer a statin
- C. Recommend against a statin
- D. Insufficient evidence to recommend
Best answer: B. For adults 40 to 75 with one or more CVD risk factors and a 10-year risk of 7.5% to under 10%, USPSTF recommends that clinicians selectively offer a statin. Grade C.
- A is not the best answer. Routine prescribing is the recommendation at 10% risk or higher.
- C is not the best answer. USPSTF does not recommend against statins in this group.
- D is not the best answer. This group has a C grade, not an I statement.
Question 3: Aspirin at 65
A 65-year-old with a 10-year CVD risk of 14% and no history of CVD asks whether to start daily low-dose aspirin. What does USPSTF recommend?
- A. Start low-dose aspirin, since risk exceeds 10%
- B. Individual decision based on bleeding risk
- C. Start full-dose aspirin
- D. Recommend against initiating low-dose aspirin for primary prevention
Best answer: D. USPSTF recommends against initiating low-dose aspirin for primary prevention of CVD in adults 60 or older. Grade D. The 10% risk threshold applies to the 40 to 59 group.
- A is not the best answer. Risk above 10% does not change the age-based D recommendation for 60 and older.
- B is not the best answer. An individual decision is the USPSTF approach for ages 40 to 59 with 10% or greater risk.
- C is not the best answer. Full-dose aspirin is not part of the recommendation.
Question 4: Aspirin at 50
A 50-year-old with a 10-year CVD risk of 11% and no increased bleeding risk asks about low-dose aspirin. What is the USPSTF position?
- A. Recommend against
- B. Recommend for all
- C. The decision should be an individual one; net benefit is small
- D. Insufficient evidence
Best answer: C. For adults 40 to 59 with a 10-year CVD risk of 10% or greater, USPSTF says the decision to start low-dose aspirin should be an individual one, because the net benefit is small. People not at increased bleeding risk and willing to take it daily are more likely to benefit. Grade C.
- A is not the best answer. The D recommendation applies to adults 60 and older.
- B is not the best answer. USPSTF does not recommend aspirin for everyone in this group.
- D is not the best answer. This group has a C grade, not an I statement.
Screening
Question 5: Confirming hypertension
A 38-year-old has an office blood pressure of 146/94 mm Hg at a routine visit. What does USPSTF recommend before starting treatment?
- A. Obtain blood pressure measurements outside the clinical setting to confirm the diagnosis
- B. Start a thiazide today
- C. Order an echocardiogram
- D. Repeat the office reading in 5 years
Best answer: A. USPSTF recommends screening adults 18 and older with office blood pressure measurement and obtaining measurements outside the clinical setting for diagnostic confirmation before starting treatment. Grade A.
- B is not the best answer. USPSTF calls for confirmation before treatment.
- C is not the best answer. Echocardiography is not part of the screening recommendation.
- D is not the best answer. An elevated reading calls for confirmation now, not a repeat in years.
Question 6: Aneurysm screening in a former smoker
A 68-year-old man quit smoking 20 years ago. He has no symptoms. What does USPSTF recommend about abdominal aortic aneurysm?
- A. No screening, because he quit
- B. Annual ultrasonography
- C. One-time screening with ultrasonography
- D. CT angiography
Best answer: C. USPSTF recommends one-time AAA screening with ultrasonography in men aged 65 to 75 who have ever smoked. Quitting does not remove him from the "ever smoked" group. Grade B.
- A is not the best answer. "Ever smoked" includes former smokers.
- B is not the best answer. The recommendation is for a single screen, not annual imaging.
- D is not the best answer. The recommended test is ultrasonography.
Question 7: Men who never smoked
A 70-year-old man has never smoked. What is the USPSTF approach to AAA screening for him?
- A. Routine one-time screening
- B. Recommend against screening
- C. Screen every 2 years
- D. Selectively offer screening rather than routinely screening all men in this group
Best answer: D. For men 65 to 75 who have never smoked, USPSTF recommends that clinicians selectively offer AAA screening with ultrasonography rather than routinely screening all men in this group.
- A is not the best answer. Routine screening is the recommendation for men who have ever smoked.
- B is not the best answer. USPSTF does not recommend against screening in this group.
- C is not the best answer. The recommendation is not a repeating schedule.
Question 8: Carotid screening
A 58-year-old with no neurologic symptoms asks for a carotid ultrasound because a friend had a stroke. What does USPSTF recommend?
- A. Order carotid duplex ultrasound for all adults over 50
- B. Recommend against screening for asymptomatic carotid artery stenosis in the general adult population
- C. Order a carotid ultrasound if a bruit is absent
- D. Screen every 3 years after age 55
Best answer: B. USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. Grade D.
- A is not the best answer. USPSTF recommends against routine screening in asymptomatic adults.
- C is not the best answer. The absence of a bruit is not an indication.
- D is not the best answer. There is no recommended screening interval because screening is not recommended.
Question 9: A screening ECG
A healthy, asymptomatic 44-year-old at low cardiovascular risk asks for an ECG "to be safe." What does USPSTF recommend?
- A. Resting ECG every 5 years
- B. Exercise ECG once
- C. Recommend against screening with resting or exercise ECG in low-risk asymptomatic adults
- D. Insufficient evidence
Best answer: C. USPSTF recommends against screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at low risk. Grade D. For intermediate or high risk, USPSTF finds the evidence insufficient.
- A is not the best answer. Screening is not recommended at low risk.
- B is not the best answer. Exercise ECG is included in the recommendation against screening.
- D is not the best answer. The I statement applies to intermediate or high risk, not low risk.
Question 10: Screening for atrial fibrillation
A 72-year-old without symptoms asks whether she should be screened for atrial fibrillation. What does USPSTF conclude?
- A. Screen all adults 50 and older (Grade A)
- B. Recommend against screening (Grade D)
- C. Screen only women
- D. Evidence is insufficient to assess benefits and harms (I statement)
Best answer: D. USPSTF concludes that current evidence is insufficient to assess the balance of benefits and harms of screening asymptomatic adults 50 or older for atrial fibrillation. It is an I statement, not a recommendation for or against.
- A is not the best answer. USPSTF does not give screening an A grade.
- B is not the best answer. USPSTF does not recommend against it either.
- C is not the best answer. The statement covers asymptomatic adults 50 and older regardless of sex.
Drug safety
Question 11: An ACE inhibitor and pregnancy
A 31-year-old taking lisinopril for hypertension has a positive pregnancy test. What does the lisinopril boxed warning direct?
- A. Continue lisinopril and add a second agent
- B. Discontinue lisinopril as soon as possible
- C. Reduce the dose by half
- D. Continue until the second trimester
Best answer: B. The boxed warning says that when pregnancy is detected, lisinopril should be discontinued as soon as possible, because drugs acting directly on the renin-angiotensin system can cause fetal injury and death.
- A is not the best answer. Continuing is what the boxed warning tells you not to do.
- C is not the best answer. Dose reduction does not address the fetal risk.
- D is not the best answer. The warning says to stop as soon as possible, not to wait.
Question 12: Switching to sacubitril/valsartan
A patient with heart failure with reduced ejection fraction is switching from enalapril to sacubitril/valsartan. What does the Entresto label require?
- A. Allow a 36-hour washout between the two drugs
- B. Take both together for one week
- C. Stop enalapril the day after starting Entresto
- D. No washout is needed
Best answer: A. The label says Entresto is contraindicated with concomitant ACE inhibitor use, and that when switching from an ACE inhibitor, a washout period of 36 hours must separate the two drugs.
- B is not the best answer. Concomitant use is contraindicated.
- C is not the best answer. Overlap is not allowed.
- D is not the best answer. The label specifies a 36-hour washout.
Question 13: Spironolactone contraindications
Which lab finding is a contraindication to starting spironolactone on its label?
- A. Hypokalemia
- B. Hyponatremia alone
- C. Elevated LDL cholesterol
- D. Hyperkalemia
Best answer: D. The spironolactone label lists hyperkalemia, Addison's disease and concomitant eplerenone as contraindications. Spironolactone raises serum potassium.
- A is not the best answer. The label notes spironolactone can be useful when other diuretics have caused hypokalemia, so a low potassium is not a contraindication.
- B is not the best answer. Hyponatremia is not listed as a contraindication.
- C is not the best answer. LDL is unrelated to the label's contraindications.
USPSTF grades in this set
| Topic | Population | Grade |
|---|---|---|
| Statin, primary prevention | Ages 40 to 75, at least 1 risk factor, 10-year risk 10% or more | B |
| Statin, primary prevention | Ages 40 to 75, at least 1 risk factor, 10-year risk 7.5% to under 10% | C |
| Low-dose aspirin, primary prevention | Ages 40 to 59 with 10-year risk 10% or more | C |
| Low-dose aspirin, primary prevention | Ages 60 and older | D |
| Hypertension screening | Adults 18 and older | A |
| AAA ultrasound, one time | Men 65 to 75 who have ever smoked | B |
| Carotid stenosis screening | Asymptomatic general adult population | D |
| ECG screening | Asymptomatic adults at low CVD risk | D |
| Atrial fibrillation screening | Asymptomatic adults 50 and older | I |
How should you use this set?
For each screening or prevention item, find the population first (age, sex, risk factor, risk percentage), then the grade. Most errors come from applying a threshold to the wrong age group, as with aspirin at 60. For drug items, the label rule is the answer: washout, contraindication, boxed warning. For timed practice across the blueprint, see FNP-C exam prep, and if you are deciding between the two FNP exams, read the AANP vs ANCC FNP comparison.
References
- [1] USPSTF (2022). Statin Use for the Primary Prevention of CVD in Adults. USPSTF. USPSTF
- [2] USPSTF (2022). Aspirin Use to Prevent Cardiovascular Disease. USPSTF. USPSTF
- [3] USPSTF (2021). Hypertension in Adults: Screening. USPSTF. USPSTF
- [4] USPSTF (2019). Abdominal Aortic Aneurysm: Screening. USPSTF. USPSTF
- [5] USPSTF (2021). Asymptomatic Carotid Artery Stenosis: Screening. USPSTF. USPSTF
- [6] USPSTF (2018). Cardiovascular Disease Risk: Screening With Electrocardiography. USPSTF. USPSTF
- [7] USPSTF (2022). Atrial Fibrillation: Screening. USPSTF. USPSTF
- [8] FDA label (2026). Lisinopril tablets. FDA label. FDA label
- [9] FDA label (2026). Entresto (sacubitril and valsartan). FDA label. FDA label
- [10] FDA label (2026). Spironolactone tablets. FDA label. FDA label
Help us improve this guide
How helpful was this article?
One tap helps us understand what’s useful.
Frequently asked questions
Prevention and screening are part of the assess and plan domains on the NPCB FNP blueprint, and USPSTF recommendations are the usual reference for primary-care screening and preventive medication questions.
USPSTF recommends prescribing a statin for adults 40 to 75 with at least one CVD risk factor and a 10-year risk of 10% or more, and selectively offering one at 7.5% to under 10%.
No. USPSTF recommends against starting low-dose aspirin for primary prevention at age 60 or older.
Men 65 to 75 who have ever smoked get one-time ultrasound screening. For men in that age group who never smoked, USPSTF says to selectively offer it.
The Entresto label requires 36 hours.
No. They are original PrepSolution practice items written from the USPSTF and FDA label sources listed under References. They have not been reviewed by a credentialed nurse practitioner and are not clinical guidance.
Keep practicing for the FNP-C.
Review the study tools, access options and price, or start with free practice.
Related Articles
FNP Pharmacology Practice Questions: Boxed Warnings and Label Rules
Eleven original FNP pharmacology questions on contraindications, boxed warnings and administration rules for common primary-care drugs, each keyed to the FDA label.
AANP FNP Exam Blueprint: Domains, Age Groups and Question Counts
The AANP FNP exam has 135 scored questions split across four domains and eight age groups. See every count from the 2024 blueprint, the tasks under each domain, and what the blueprint leaves out.
FNP Women's Health Practice Questions: 12 With Rationales
Twelve original FNP women's health questions on USPSTF screening grades, pregnancy prevention, CDC STI regimens and contraceptive eligibility, each keyed to a named source.
